xlm digital currency, Overview

Kaidianbao suspended the payment business. On December 11th, Kaidianbao Payment Service Co., Ltd. announced that due to the change of business conditions, in order to protect the interests of merchants and partners to the greatest extent, the company decided to suspend the payment business, and from now on, the existing stock business will be withdrawn and cleaned in an orderly manner, and the businesses with potential risks will be cleaned up before December 20th, 2024. All stock payment services will be suspended after December 31, 2024. Regarding why the business was suspended, the reporter interviewed the legal representative of the company, but did not get a response from the other party. (beijing business today)The dividend low-wave ETF(512890) attracted 2.35 billion yuan in the last five days, with the latest scale of 10.8 billion yuan. On December 11th, the dividend low-wave ETF(512890) rose by 0.27%, with a turnover of 234 million yuan and the latest scale of 10.8 billion yuan. In terms of capital flow, it attracted 2.35 billion yuan in the last five days and 2.81 billion yuan in the last 10 days. In the news, recently, the dividend-themed ETFs have been reported frequently. The fund sizes of Huatai Bairui Dividend ETF and Huatai Bairui Dividend Low Wave ETF, the two largest dividend-themed ETFs in the whole market, exceeded 20 billion yuan and 10 billion yuan respectively. Huatai Berry dividend ETF has become the first dividend-themed ETF with a scale of 20 billion in the whole market. Huatai Bairui Fund said that on the one hand, this year's insurance funds frequently placarded, indicating that the pace of insurance funds entering the market has accelerated; On the other hand, the yield of 10-year treasury bonds has continued to decline and has entered the "1" era. Under the low interest rate environment, it has become inevitable that medium and long-term funds will increase the overall investment income by allocating equity assets. Investors can borrow the dividend low-wave ETF(512890) and its linked funds (Class A 007466, Class C 007467) layout.Shanxi procuratorate decided to arrest Wu Huatai in accordance with the law. The case of former party secretary and chairman of Shanxi Coking Coal Group Co., Ltd. Wu Huatai (director level) suspected of accepting bribes and abuse of power by state-owned company personnel was investigated by Shanxi Provincial Supervision Committee and transferred to the procuratorate for review and prosecution. Under the jurisdiction designated by the Shanxi Provincial People's Procuratorate, the Taiyuan Railway Transportation Branch of the Shanxi Provincial People's Procuratorate reviewed and prosecuted. A few days ago, Taiyuan Railway Transportation Branch of Shanxi Provincial People's Procuratorate made an arrest decision against Wu Huatai on suspicion of accepting bribes and abuse of power by state-owned company personnel. The case is being further processed.

Port-au-Prince Airport in Haiti will resume normal operation. On December 10th, local time, Haitian Aviation Management Committee announced that Toussaint Louvertur International Airport in Port-au-Prince will resume normal operation on the 11th. Toussaint Louverture International Airport, located in Port-au-Prince, Haiti, is the largest airport in the country. In March this year, Haitian gang militants attacked the airport in an attempt to seize control. Since then, the operation of the airport has been blocked, and most airlines have cancelled flights to Haiti. (CCTV News)The wide currency and weak credit logic may continue, and the upward direction of the market volatility will not change. The Shanghai and Shenzhen 300ETF South (159925) is gaining momentum. On December 11, the Shanghai and Shenzhen 300ETF South (159925) closed down by 0.25%, with a turnover of 75,892,100 yuan. The constituent stocks are mixed. In terms of rising, Midea Group led the rise, and Changjiang Power followed suit. In terms of decline, China Ping An led the decline, while Contemporary Amperex Technology Co., Limited followed. In the news, Contemporary Amperex Technology Co., Limited, the power battery giant, once again announced that it will build a power battery factory overseas, which will also become the company's third battery factory in Europe. Bank of China Securities said that the important meeting at the end of the year is about to land, and the market may face fluctuations caused by the expected landing of policies in the short term, but the tone of monetary policy will not change. The logic of "wide money+weak credit" will continue in the short term. Under the expectation of loose monetary policy, the upward direction of market volatility will not change. According to industry insiders, looking forward to 2025, the allocation of A-share industry can be developed around three main lines: first, the direction of domestic macro-circulation, attaching importance to "duality and innovation", "debt conversion" and new growth points in the consumption field; Second, science and technology are self-reliant: pay attention to artificial intelligence industry, self-controllable, new energy technology, aerospace information technology and data elements; The third is to open wider to the outside world: pay attention to cross-border e-commerce, digital trade, tax exemption and inbound tourism. You can use the Shanghai and Shenzhen 300ETF South (159925) to lay out the core assets with one click.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.

Huize released its Q3 results in 2024, and the number of insured customers exceeded 10 million. On December 10th, HUIZ.US, an insurance e-commerce service platform, released its unaudited Q3 results report in the third quarter of 2024 (hereinafter referred to as "Q3") before the opening of the US stock market. The data shows that during Q3, Huixuan contributed a total premium of 2.06 billion yuan (RMB, the same below), a total revenue of 370 million yuan and a net profit of 18.7 million yuan. After experiencing rapid growth since the reform and opening up, China's economy is entering a new normal of medium-speed development. In 2024, opportunities and challenges coexist in the insurance industry. Q3 financial report data shows that Huixuan's accumulated insured customers have exceeded 10 million.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Market News: The Knesset group approved a bill to increase deficit ratio's GDP to 7.7%, which will be submitted to the Knesset plenary session for voting.